|
시장보고서
상품코드
2070375
화학정보학 시장 : 규모, 점유율, 성장, 산업 분석, 지역 인사이트 및 예측(2026-2034년)Cheminformatics Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
화학정보학 시장의 성장 요인
세계 화학정보학 시장은 2025년에 13억 5,000만 달러로 평가되었고, 2026년의 14억 5,000만 달러에서 2034년까지 26억 5,000만 달러로 성장할 것으로 예상되며, 예측 기간 동안 연평균 성장률(CAGR) 7.86%를 나타낼 것으로 전망됩니다. 화학정보학에서는 디지털 도구, 소프트웨어, 데이터베이스 및 데이터 기반 모델을 활용하여 화학 구조, 분자 특성, 반응, 화합물 정보의 저장, 검색, 분석 및 해석을 수행합니다.
이 시장은 보다 신속하고 비용 효율적인 신약 개발에 대한 수요 증가, 화합물 등록 및 구조 검색 도구의 활용 확대, 제약사 및 생명공학 기업의 도입 확대, 그리고 AI를 활용한 분자 설계에 대한 관심 고조로 인해 성장하고 있습니다. 2025년에는 북미가 39.25%의 시장 점유율을 차지하며 시장을 주도했습니다.
화학정보학 시장 동향
시장의 주요 동향으로는 신약 개발 분야에서 인공지능(AI) 및 머신러닝(ML)의 도입 확대가 꼽힙니다. AI와 ML은 연구자들이 대규모 화학 및 생물학적 데이터 세트를 분석하고, 유망한 분자를 식별하며, 가상 스크리닝을 개선하고, 분자 특성을 예측하며, 선도 화합물의 최적화를 지원하고, 합성 경로를 계획하는 데 도움을 줍니다. 이에 따라 케미인포매틱스는 단순한 지원 도구에서 현대 연구 개발의 전략적 의사결정 플랫폼으로 그 역할을 전환해 가고 있습니다.
2025년 8월, CAS는 연구 개발 효율을 높이고 혁신을 가속화하기 위해 CAS SciFinder에 새로운 ‘사이언스 스마트’ AI 기능을 통합했다고 발표했습니다.
시장 성장 촉진요인
제약 업계에서 연구개발비 증가는 시장 성장의 주요 촉진요인입니다. 제약 기업들이 의약품 파이프라인을 확대함에 따라, 화합물 등록, 구조 검색, 가상 스크리닝, 선도 화합물 최적화, 그리고 ADME/물성 예측을 위한 첨단 도구가 필요해지고 있습니다. 연구개발 예산 증가는 클라우드 기반 공동 화학정보학 플랫폼의 도입을 뒷받침하고 있습니다.
2025년 4월, 노바티스는 샌디에이고 연구 거점을 포함해 미국 내 제조 및 연구개발 거점을 확대하기 위해 향후 5년간 230억 달러를 투자할 계획이라고 발표했습니다. 이러한 투자는 디지털 케미스트리 및 신약 개발 플랫폼에 대한 수요를 뒷받침하고 있습니다.
시장 성장 억제요인
높은 도입 비용이 주요 제약 요인으로 작용하고 있습니다. 케미인포매틱스를 도입하려면 소프트웨어 라이선스 취득, 도입, 통합, 데이터 마이그레이션, 맞춤 설정, 검증, 직원 교육 및 지속적인 지원이 필요합니다. 소규모 생명공학 기업, 학술 기관 및 예산이 제한적인 연구 기관은 초기 비용의 부담과 복잡성 때문에 도입을 미룰 가능성이 있습니다.
시장 기회
신약 및 의약품 개발에 대한 투자 확대는 화학정보학 업체들에게 큰 기회를 제공합니다. 제약 회사와 생명공학 기업들은 분자를 보다 효율적으로 식별, 선별 및 최적화하기 위한 디지털 도구가 필요합니다. 또한, AI, 시뮬레이션 기반 신약 개발, 클라우드 기반 협업의 활용 확대 역시 소프트웨어, 데이터베이스, 서비스 제공업체의 수익 기회를 확대되고 있습니다.
2025년 9월, 암젠은 캘리포니아주에 신설될 과학·혁신 센터에 6억 달러 이상을 투자할 계획을 발표하며, 첨단 분자 설계 및 연구 워크플로우 도구에 대한 수요를 뒷받침하고 있습니다.
시장의 과제
저·중소득 국가에서 숙련된 전문 인력의 부족은 주요 과제 중 하나입니다. 케미인포매틱스 분야에서는 화학, 분자 모델링, 데이터 분석 및 디지털 연구 워크플로우에 대한 전문 지식이 요구됩니다. 훈련을 받은 인력을 확보하기 어려워, 가상 스크리닝, 물성 예측, 반응 계획과 같은 첨단 도구의 효과적인 도입이 저해되고 있습니다.
지역별 분석
북미는 2025년에 5억 3,000만 달러를 기록하며, 2024년의 4억 9,000만 달러에서 증가해 세계 시장을 주도했습니다. 미국 시장은 2026년에 5억 2,000만 달러에 달할 것으로 예상되며, 이는 전 세계 매출의 약 35.7%를 차지하게 됩니다.
유럽은 활발한 제약 연구, 학술 네트워크 및 공공 자금 지원 프로그램의 뒷받침을 받아 연평균 성장률(CAGR) 6.27%를 나타낼 것으로 예측됩니다. 2026년 영국 시장은 8,000만 달러로 추산되며, 독일 시장은 9,000만 달러에 달할 것으로 전망됩니다.
아시아태평양은 생명공학 활동의 활성화, CRO/CDMO의 확대, 그리고 디지털 연구 인프라의 개선에 힘입어 2026년에는 3억 8,000만 달러에 달할 것으로 예측됩니다. 2026년 시장 규모는 일본이 8,000만 달러, 중국이 약 1억 달러, 인도가 4,000만 달러로 추산됩니다.
라틴아메리카 시장은 2026년에 6,000만 달러에 달할 것으로 추정되며, GCC 시장은 3,000만 달러에 이를 것으로 전망됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 역학
제4장 주요 인사이트
제5장 세계의 화학정보학 시장 분석, 인사이트 및 예측(2021-2034년)
제6장 북미 화학정보학 시장 분석, 인사이트 및 예측(2021-2034년)
제7장 유럽 화학정보학 시장 분석, 인사이트 및 예측(2021-2034년)
제8장 아시아태평양 화학정보학 시장 분석, 인사이트 및 예측(2021-2034년)
제9장 라틴아메리카 화학정보학 시장 분석, 인사이트 및 예측(2021-2034년)
제10장 중동 및 아프리카 화학정보학 시장 분석, 인사이트 및 예측(2021-2034년)
제11장 경쟁 분석
JHS 26.07.01Growth Factors of cheminformatics Market
The global cheminformatics market was valued at USD 1.35 billion in 2025 and is projected to grow from USD 1.45 billion in 2026 to USD 2.65 billion by 2034, registering a CAGR of 7.86% during the forecast period. Cheminformatics uses digital tools, software, databases, and data-driven models to store, search, analyze, and interpret chemical structures, molecular properties, reactions, and compound information.
The market is growing due to rising demand for faster and cost-effective drug discovery, increasing use of compound registration and structure search tools, wider adoption by pharmaceutical and biotechnology companies, and growing interest in AI-assisted molecular design. North America dominated the market in 2025 with a 39.25% market share.
Cheminformatics Market Trends
A major trend in the market is the increasing adoption of artificial intelligence and machine learning in drug discovery. AI and ML help researchers analyze large chemical and biological datasets, identify promising molecules, improve virtual screening, predict molecular properties, support lead optimization, and plan synthesis routes. This is shifting cheminformatics from a support tool to a strategic decision-making platform in modern R&D.
In August 2025, CAS announced that CAS SciFinder integrated new science-smart AI capabilities to improve R&D efficiency and accelerate innovation.
Market Drivers
Rising pharmaceutical R&D spending is a key driver of market growth. As pharmaceutical companies expand their drug pipelines, they require advanced tools for compound registration, structure searching, virtual screening, lead optimization, and ADME/property prediction. Higher R&D budgets also support adoption of cloud-based and collaborative cheminformatics platforms.
In April 2025, Novartis announced a planned USD 23 billion investment over five years to expand its U.S. manufacturing and R&D footprint, including a research hub in San Diego. Such investments support demand for digital chemistry and discovery platforms.
Market Restraints
High implementation cost is a major restraint. Cheminformatics adoption requires software licensing, deployment, integration, data migration, customization, validation, staff training, and continuous support. Small biotech firms, academic institutes, and budget-limited research organizations may delay adoption due to high upfront cost and complexity.
Market Opportunities
Rising investment in drug discovery and development is creating strong opportunities for cheminformatics vendors. Pharmaceutical and biotechnology companies need digital tools to identify, screen, and optimize molecules more efficiently. Increasing use of AI, simulation-based discovery, and cloud-based collaboration is also expanding revenue opportunities for software, databases, and service providers.
In September 2025, Amgen announced plans to invest over USD 600 million in a new science and innovation center in California, supporting demand for advanced molecular design and research workflow tools.
Market Challenges
Lack of skilled professionals in low- and middle-income countries is a key challenge. Cheminformatics requires expertise in chemistry, molecular modeling, data analysis, and digital research workflows. Limited availability of trained personnel reduces effective adoption of advanced tools such as virtual screening, property prediction, and reaction planning.
Segment Analysis
By component, the market is divided into software, databases/content platforms, and services. The software segment dominated the market in 2025 due to its central role in compound registration, structure search, virtual screening, lead optimization, property prediction, and chemistry data management. The services segment is expected to grow at a CAGR of 11.00%.
By deployment, the market includes on-premise, cloud/web-based, and hybrid. The on-premise segment led the market in 2025 and is expected to hold 45.3% share in 2026, driven by strong demand for data security, internal system control, and integration with existing ELN, LIMS, and compound registration systems. The cloud/web-based segment is projected to grow at a CAGR of 11.29%.
By application, the market is segmented into compound registration & search, hit discovery & virtual screening, lead optimization, ADME/toxicity/property prediction, reaction planning & synthesis design, chemical data management & decision support, and others. The compound registration & search segment dominated in 2025 and is expected to hold 22.1% share in 2026, as it forms the first layer of cheminformatics adoption. The reaction planning & synthesis design segment is projected to grow at a CAGR of 10.57%.
By end user, pharmaceutical & biotechnology companies dominated in 2025 and are expected to hold 49.2% share in 2026. Strong R&D budgets, large molecular datasets, and demand for faster discovery workflows support this segment. CROs & CDMOs are expected to grow at a CAGR of 10.97%.
Regional Analysis
North America led the global market with USD 0.53 billion in 2025, rising from USD 0.49 billion in 2024. The U.S. market is projected to reach USD 0.52 billion in 2026, representing about 35.7% of global revenue.
Europe is expected to grow at a CAGR of 6.27%, supported by strong pharmaceutical research, academic networks, and public funding programs. The U.K. market is estimated at USD 0.08 billion in 2026, while Germany is projected to reach USD 0.09 billion.
Asia Pacific is expected to reach USD 0.38 billion in 2026, driven by growing biotech activity, CRO/CDMO expansion, and improving digital research infrastructure. Japan is estimated at USD 0.08 billion, China at around USD 0.10 billion, and India at USD 0.04 billion in 2026.
Latin America is estimated at USD 0.06 billion in 2026, while the GCC market is projected to reach USD 0.03 billion.
Competitive Landscape
The market is moderately consolidated, with key players including Schrodinger, Dassault Systemes, Cadence Design Systems, Certara, Cresset, Siemens Dotmatics, American Chemical Society, Optibrium, BioSolveIT, Molecular Discovery, and Enamine. Companies focus on platform upgrades, AI-driven discovery capabilities, cloud-native tools, and integrated chemistry workflows.
Key Industry Developments
In January 2026, CAS launched CAS Intelligence Hub for scientific data management. In November 2025, Optibrium released StarDrop 8. In July 2025, Cresset acquired Molab.ai to strengthen AI-based drug discovery. In July 2024, Certara agreed to acquire ChemAxon, expanding its cheminformatics software capabilities.
Conclusion
The cheminformatics market is expected to grow from USD 1.35 billion in 2025 to USD 1.45 billion in 2026, reaching USD 2.65 billion by 2034. Growth will be driven by AI-enabled drug discovery, rising pharmaceutical R&D spending, cloud-based research platforms, and demand for faster molecule screening and optimization. Despite high implementation costs and skill shortages, cheminformatics will remain essential for modern chemistry-focused R&D.
Segmentation By Component, Deployment, Application, End User, and Region
By Component * Software
- Databases/Content Platforms
- Services
By Deployment * On-premise
- Cloud / Web-based
- Hybrid
By Application * Compound Registration & Search
- Hit Discovery & Virtual Screening
- Lead Optimization
- ADME/Toxicity /Property Prediction
- Reaction Planning & Synthesis Design
- Chemical Data Management & Decision Support
- Others
By End User * Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Chemical Companies
- CROs & CDMOs
- Others
By Region * North America (By Component, Deployment, Application, End User, and Country)
- U.S.
- Canada
- Europe (By Component, Deployment, Application, End User, and Country/Sub-region)
- Germany
- U.K.
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Component, Deployment, Application, End User, and Country/Sub-region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Component, Deployment, Application, End User, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Component, Deployment, Application, End User, and Country/Sub-region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Technological Advancements in Cheminformatics
- 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.3. New Product Launches, By Key Players
- 4.4. Key Start-ups in this Market
5. Global Cheminformatics Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Component
- 5.1.1. Software
- 5.1.2. Databases/Content Platforms
- 5.1.3. Services
- 5.2. Market Analysis, Insights and Forecast - By Deployment
- 5.2.1. On-premise
- 5.2.2. Cloud / Web-based
- 5.2.3. Hybrid
- 5.3. Market Analysis, Insights and Forecast - By Application
- 5.3.1. Compound Registration & Search
- 5.3.2. Hit Discovery & Virtual Screening
- 5.3.3. Lead Optimization
- 5.3.4. ADME / Toxicity / Property Prediction
- 5.3.5. Reaction Planning & Synthesis Design
- 5.3.6. Chemical Data Management & Decision Support
- 5.3.7. Others
- 5.4. Market Analysis, Insights and Forecast - By End User
- 5.4.1. Pharmaceutical & Biotechnology Companies
- 5.4.2. Academic & Research Institutes
- 5.4.3. Chemical Companies
- 5.4.4. CROs & CDMOs
- 5.4.5. Others
- 5.5. Market Analysis, Insights and Forecast - Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Cheminformatics Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Component
- 6.1.1. Software
- 6.1.2. Databases/Content Platforms
- 6.1.3. Services
- 6.2. Market Analysis, Insights and Forecast - By Deployment
- 6.2.1. On-premise
- 6.2.2. Cloud / Web-based
- 6.2.3. Hybrid
- 6.3. Market Analysis, Insights and Forecast - By Application
- 6.3.1. Compound Registration & Search
- 6.3.2. Hit Discovery & Virtual Screening
- 6.3.3. Lead Optimization
- 6.3.4. ADME / Toxicity / Property Prediction
- 6.3.5. Reaction Planning & Synthesis Design
- 6.3.6. Chemical Data Management & Decision Support
- 6.3.7. Others
- 6.4. Market Analysis, Insights and Forecast - By End User
- 6.4.1. Pharmaceutical & Biotechnology Companies
- 6.4.2. Academic & Research Institutes
- 6.4.3. Chemical Companies
- 6.4.4. CROs & CDMOs
- 6.4.5. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Cheminformatics Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Component
- 7.1.1. Software
- 7.1.2. Databases/Content Platforms
- 7.1.3. Services
- 7.2. Market Analysis, Insights and Forecast - By Deployment
- 7.2.1. On-premise
- 7.2.2. Cloud / Web-based
- 7.2.3. Hybrid
- 7.3. Market Analysis, Insights and Forecast - By Application
- 7.3.1. Compound Registration & Search
- 7.3.2. Hit Discovery & Virtual Screening
- 7.3.3. Lead Optimization
- 7.3.4. ADME / Toxicity / Property Prediction
- 7.3.5. Reaction Planning & Synthesis Design
- 7.3.6. Chemical Data Management & Decision Support
- 7.3.7. Others
- 7.4. Market Analysis, Insights and Forecast - By End User
- 7.4.1. Pharmaceutical & Biotechnology Companies
- 7.4.2. Academic & Research Institutes
- 7.4.3. Chemical Companies
- 7.4.4. CROs & CDMOs
- 7.4.5. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific Cheminformatics Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Component
- 8.1.1. Software
- 8.1.2. Databases/Content Platforms
- 8.1.3. Services
- 8.2. Market Analysis, Insights and Forecast - By Deployment
- 8.2.1. On-premise
- 8.2.2. Cloud / Web-based
- 8.2.3. Hybrid
- 8.3. Market Analysis, Insights and Forecast - By Application
- 8.3.1. Compound Registration & Search
- 8.3.2. Hit Discovery & Virtual Screening
- 8.3.3. Lead Optimization
- 8.3.4. ADME / Toxicity / Property Prediction
- 8.3.5. Reaction Planning & Synthesis Design
- 8.3.6. Chemical Data Management & Decision Support
- 8.3.7. Others
- 8.4. Market Analysis, Insights and Forecast - By End User
- 8.4.1. Pharmaceutical & Biotechnology Companies
- 8.4.2. Academic & Research Institutes
- 8.4.3. Chemical Companies
- 8.4.4. CROs & CDMOs
- 8.4.5. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.5.1. China
- 8.5.2. Japan
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America Cheminformatics Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Component
- 9.1.1. Software
- 9.1.2. Databases/Content Platforms
- 9.1.3. Services
- 9.2. Market Analysis, Insights and Forecast - By Deployment
- 9.2.1. On-premise
- 9.2.2. Cloud / Web-based
- 9.2.3. Hybrid
- 9.3. Market Analysis, Insights and Forecast - By Application
- 9.3.1. Compound Registration & Search
- 9.3.2. Hit Discovery & Virtual Screening
- 9.3.3. Lead Optimization
- 9.3.4. ADME / Toxicity / Property Prediction
- 9.3.5. Reaction Planning & Synthesis Design
- 9.3.6. Chemical Data Management & Decision Support
- 9.3.7. Others
- 9.4. Market Analysis, Insights and Forecast - By End User
- 9.4.1. Pharmaceutical & Biotechnology Companies
- 9.4.2. Academic & Research Institutes
- 9.4.3. Chemical Companies
- 9.4.4. CROs & CDMOs
- 9.4.5. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Cheminformatics Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Component
- 10.1.1. Software
- 10.1.2. Databases/Content Platforms
- 10.1.3. Services
- 10.2. Market Analysis, Insights and Forecast - By Deployment
- 10.2.1. On-premise
- 10.2.2. Cloud / Web-based
- 10.2.3. Hybrid
- 10.3. Market Analysis, Insights and Forecast - By Application
- 10.3.1. Compound Registration & Search
- 10.3.2. Hit Discovery & Virtual Screening
- 10.3.3. Lead Optimization
- 10.3.4. ADME / Toxicity / Property Prediction
- 10.3.5. Reaction Planning & Synthesis Design
- 10.3.6. Chemical Data Management & Decision Support
- 10.3.7. Others
- 10.4. Market Analysis, Insights and Forecast - By End User
- 10.4.1. Pharmaceutical & Biotechnology Companies
- 10.4.2. Academic & Research Institutes
- 10.4.3. Chemical Companies
- 10.4.4. CROs & CDMOs
- 10.4.5. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Schrodinger, Inc.
- 11.2.2. Certara
- 11.2.3. Dassault Systemes
- 11.2.4. Siemens (Dotmatics)
- 11.2.5. Cadence Design Systems, Inc.
- 11.2.6. American Chemical Society
- 11.2.7. Optibrium Ltd
- 11.2.8. Cresset
- 11.2.9. BioSolveIT GmbH
- 11.2.10. Molecular Discovery
- 11.2.11. Enamine ltd
